Published 3 years ago

Vietnam approves Cuba's Abdala vaccine for use against COVID

Summary by Reuters

HANOI - Vietnam has approved Cuba's Abdala vaccine for use against the new coronavirus, the government said on Saturday. Abdala becomes the eighth COVID-19 vaccine approved for use in Vietnam, which is battling its worst outbreak in months. (Editing by William Mallard)

0 Articles

All

Left

Center

Right

Reuters

Vietnam approves Cuba's Abdala vaccine for use against COVID

3 years ago·United Kingdom

Read Full Article

NDTV

Vietnam Approves Cuba's Abdala Vaccine Amid Its Worst Covid Outbreak

Vietnam has approved Cuba's Abdala vaccine for use against the new coronavirus, the government said on Saturday, as the Southeast Asian country is battling its worst outbreak.

3 years ago·New Delhi, India

Read Full Article

CNN

Vietnam approves Cuba's Abdala vaccine as Delta variant outbreak continues

Vietnam has approved Cuba's Abdala vaccine for use against the coronavirus, the government said on Saturday, as the Southeast Asian country battles its worst outbreak of the pandemic.

3 years ago·Atlanta, United States

Read Full Article

Channel News Asia

Vietnam approves Cuba's Abdala COVID-19 vaccine

HANOI: Vietnam has approved Cuba's Abdala vaccine for use against the coronavirus, the government said on Saturday (Sep 18), as the Southeast Asian country is battling its worst outbreak. Abdala becomes the eighth COVID-19 vaccine approved for use in Vietnam, which has one of the lowest vaccination rates i

3 years ago·Singapore

Read Full Article

Today

Vietnam approves Cuba's Abdala vaccine for use against COVID

HANOI - Vietnam has approved Cuba's Abdala vaccine for use against the new coronavirus, the government said on Saturday.

3 years ago·Singapore

Read Full Article

Bangkok Post

Vietnam approves Cuban vaccine

HANOI: Vietnam has approved a Cuban vaccine for use against the coronavirus, the government said on Saturday, as the country continues to battle its worst outbreak yet.

3 years ago·กทม, Thailand

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.